JUNO THERAPEUTICS, INC.
SEATTLE, WA

It’s an audacious mission—a quest to radically change the course of medicine. We’re aligning our investments in scientific research, manufacturing – and most of all, people – to change the way cancer and other serious diseases are treated. To all Juno Therapeutics website visitors: Juno Therapeutics is proud to announce it is now a Celgene company. If you would like to access information about Juno and its products and pipeline, please click here: Juno Therapeutics GMBH – Gottingen, Germany Rudolf-Wissell-Straße 28 37079 Juno Therapeutics GMBH – Munich, Germany

KEY FACTS ABOUT JUNO THERAPEUTICS, INC.

Company name
JUNO THERAPEUTICS, INC.
Status
Active
Filed Number
F17000002386
FEI Number
46-3656275
Date of Incorporation
May 25, 2017
Age - 8 years
Home State
DE
Company Type
Foreign for Profit

CONTACTS

Website
http://junotherapeutics.com
Phones
(206) 582-1600

JUNO THERAPEUTICS, INC. NEAR ME

Principal Address
400 Dexter Avenue North,
Suite 1200,
Seattle,
WA,
98109,
US

See Also

Officers and Directors

The JUNO THERAPEUTICS, INC. managed by the three persons from Seattle on following positions: Vice President, Director

Amy Fallone

Position
Vice President Active
From
Seattle, WA, WA

Sophia Park

Position
Director Active
From
Seattle, WA, WA

Sandra Ramos-Alves

Position
Director Active
From
Seattle, WA, WA





Registered Agent is C T CORPORATION SYSTEM

Address
1200 SOUTH PINE ISLAND ROAD, PLANTATION, FL, 33324

Annual Reports

2025
March 20, 2025
2024
April 23, 2024